Company intelligence / Profile preview

WorldIPI

Jupiter, Florida, United States

Ownership: Private
Development stage: Other

Overview

WorldIPI primarily represents and licenses intellectual property portfolios and technologies, including a purported broad‑spectrum antiviral technology described as an "all‑strain COVID killer" that is moving into testing with the D.K. Zabolotny Institute of Microbiology and Virology of the National Academy of Science of Ukraine; available information indicates pre‑clinical/early clinical evaluation rather than a defined drug development pipeline.[3][7]

Therapeutic areas: Infectious Diseases
Industry: Drug Discovery Services

Partnerships

D.K. Zabolotny Institute of Microbiology and Virology of the National Academy of Science of Ukraine[3][7]

Beyond the preview

Go deeper on WorldIPI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WorldIPI.

Explore the full profile